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ABSTRACT
The HORMA domain is a highly conserved protein–
protein interaction module found in eukaryotic sig-
naling proteins including the spindle assembly
checkpoint protein Mad2 and the meiotic HORMAD
proteins. HORMA domain proteins interact with short
‘closure motifs’ in partner proteins by wrapping their
C-terminal ‘safety belt’ region entirely around these
motifs, forming topologically-closed complexes. Clo-
sure motif binding and release requires large-scale
conformational changes in the HORMA domain, but
such changes have only been observed in Mad2.
Here, we show that Saccharomyces cerevisiae Hop1,
a master regulator of meiotic recombination, pos-
sesses conformational dynamics similar to Mad2.
We identify closure motifs in the Hop1 binding
partner Red1 and in Hop1 itself, revealing that
HORMA domain–closure motif interactions underlie
both Hop1’s initial recruitment to the chromosome
axis and its self-assembly on the axis. We further
show that Hop1 adopts two distinct folded states
in solution, one corresponding to the previously-
observed ‘closed’ conformation, and a second more
extended state in which the safety belt region has dis-
engaged from the HORMA domain core. These data
reveal strong mechanistic similarities between mei-
otic HORMADs and Mad2, and provide a mechanistic
basis for understanding both meiotic chromosome
axis assembly and its remodeling by the AAA+ AT-
Pase Pch2/TRIP13.
INTRODUCTION
Meiosis is a specialized two-stage cell division program that
gives rise to haploid gametes in sexually reproducing or-
ganisms. After a single round of DNA replication, homol-
ogous chromosomes segregate from one another in meiosis
I, and sister chromosomes subsequently segregate in meio-
sis II. The extended prophase of meiosis I, in which ho-
mologs identify and physically associate with one another
through a modified homologous recombination pathway, is
governed by a conserved meiosis-specific protein assembly
called the chromosome axis. The axis organizes each pair
of sister chromosomes as a linear array of chromatin loops
and promotes DNA double-strand break (DSB) formation
by the conserved Spo11 endonuclease (1,2). After DSB for-
mation, axis proteins suppress repair of these DSBs via the
nearby sister chromosome, thereby promoting repair via the
homolog (3–8). This preference is key for the formation of
crossovers (COs) that enable homologs to bi-orient on the
meiosis I spindle, then properly segregate from one another
to reduce ploidy by half. In late prophase, the synaptonemal
complex assembles along the length of paired homologs’
chromosome axes, bringing the homologs into close juxta-
position and promoting the final steps of crossover forma-
tion (reviewed in (9,10)). In many organisms including the
budding yeast Saccharomyces cerevisiae, plants, and mam-
mals, synaptonemal complex assembly is coordinated with
remodeling of the chromosome axis (11–14). By deplet-
ing CO-promoting factors from homolog pairs that have
properly associated, this axis remodeling process consti-
tutes a feedback mechanism governing CO levels on a per-
chromosome basis (15,16).
The chromosome axis is highly conserved in eukaryotes.
Major axis components include cohesin complexes contain-
ing at least one meiosis-specific subunit, the kleisin Rec8
(17–21); one or more proteins of the meiotic HORMA-
domain containing (HORMAD) protein family (discussed
further below); and inmost organisms a coiled-coil domain-
containing ‘linker’ protein (S. cerevisiae Red1, S. pombe
Rec10, mammalian SYCP2/SYCP3 and plant ASY3) re-
quired for localization of HORMADs (22–28). In the bud-
ding yeast S. cerevisiae, the axis comprises Rec8-containing
*To whom correspondence should be addressed. Tel: +1 858 534 7267; Fax: +1 858 534 7750; Email: kcorbett@ucsd.edu
C© The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which
permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact
journals.permissions@oup.com
280 Nucleic Acids Research, 2018, Vol. 46, No. 1
cohesin complexes and the HORMAD protein Hop1, plus
the linker protein Red1 (28–32). In wild-type cells, Red1’s
distribution on chromosomes largely mirrors that of mei-
otic cohesin complexes (31), suggesting that Red1 may as-
sociate directly with cohesins. Red1 has also been shown to
bind directly to Hop1 both in vitro and in cells (24,33), and
is required for normal chromosome localization of Hop1
(28,31), suggesting a hierarchical cohesin→Red1→Hop1
axis assembly mechanism. Hop1, Red1, and Rec8 are all
required for normal numbers and spatial distribution of
meiotic DSBs (34–36), acting at least in part to recruit
the Rec114:Mei4:Mer2 complex to the chromosome axis
(29). These proteins are, in turn, required for Spo11 re-
cruitment to the axis and for DSB formation (37–42).
After DSBs have formed, Hop1 is phosphorylated by
the DNA damage-response kinases Mec1 and Tel1 (ho-
mologs of mammalian ATM and ATR) in its SCD region
(SQ/TQ Cluster Domain), particularly residues S298 and
T318 (5,43). This phosphorylation promotes the recruit-
ment and activation of the Mek1 kinase, which biases re-
pair of DSBs toward the homolog instead of the sister chro-
mosome, thereby generating COs (6,44–46). After CO des-
ignation and the initiation of synaptonemal complex as-
sembly, Hop1 is thought to be removed from the chromo-
some axis through the action of the conserved AAA+ AT-
Pase Pch2 (13,47,48). As chromosome-localized Hop1 pro-
motes both DSB and CO formation, its removal constitutes
a feedback mechanism suppressing further recombination
on chromosomes/regions that have already obtained COs
(13,49). Many of Hop1’s regulatory functions are shared
by its orthologs in other eukaryotes, including promoting
DSBs and biasing their repair toward the homolog, and re-
moval from the chromosome axis by Pch2 (TRIP13 inmam-
mals) in coordinationwith synaptonemal complex assembly
(11,14,50–52).
Hop1 is the founding member of the meiotic HORMAD
protein family, which also includes S. pombe Hop1, plant
ASY1/ASY2, mammalian HORMAD1/HORMAD2
and Caenorhabditis elegans HIM-3/HTP-1/HTP-2/HTP-
3 (11,27,50,53–56). The meiotic HORMADs share a
peptide-binding domain termed the HORMA domain,
named for three functionally-diverse protein families origi-
nally shown to share it: Hop1, Rev7 andMad2 (57,58). The
best-understood HORMA domain protein is Mad2, a key
regulator of the mitotic spindle assembly checkpoint. This
checkpoint monitors kinetochore-microtubule attachments
in mitosis and meiosis, and delays anaphase onset until all
kinetochores are properly attached to spindle microtubules
(59–61). The Mad2 HORMA domain can adopt two dis-
tinct stably folded conformations, termed ‘open’ (O-Mad2)
and ‘closed’ (C-Mad2) (62–64). In the closed conforma-
tion, Mad2 binds short peptides called ‘Mad2-interacting
motifs’ (MIMs) or, more generally, ‘closure motifs’ (65–67).
The two conformations of Mad2 differ mainly in the loca-
tion and conformation of its C-terminal ‘safety belt’ region:
in O-Mad2, this region is stably folded against the closure
motif binding site (-strand 6), preventing closure motif
binding (68). In C-Mad2, the safety belt is disengaged from
this site, allowing a closure motif to bind strand 6. The
safety belt in turn translocates to the opposite side of the
HORMA domain (strand 5), wrapping around the ligand
to create a topological link between HORMA domain and
closure motif (66,67,69). Coupled to safety belt motions
are changes in the domain’s N-terminus: in O-Mad2, the
N-terminus associates with strand 5 to stabilize the open
conformation. In C-Mad2, however, this region dissociates
from the HORMA domain core and is mostly disordered.
In the spindle assembly checkpoint, Mad2 is recruited to
unattached kinetochores via a closure motif on its binding
partnerMad1 (67,70). This C-Mad2 in turn recruits soluble
O-Mad2, forming a pseudo-symmetric C-Mad2:O-Mad2
dimer via a conserved surface opposite the closure motif
binding site (69,71). Mad2 dimerization promotes con-
version of O-Mad2 to the closed state and binding to a
closure motif in Cdc20, to form the core of the mitotic
checkpoint complex (72–74). Conformational conversion
of Mad2 is believed to involve a transient high-energy state
in which the safety belt has dissociated from the HORMA
domain core, which allows closure motif binding followed
by safety belt re-association to produce the C-Mad2:Cdc20
complex (62,63,75). Recently, Pch2/TRIP13 has also been
implicated in the spindle assembly checkpoint pathway,
acting with an adapter protein, p31comet, to disassemble the
MAD2:Cdc20 complex upon checkpoint silencing (76–82).
The close evolutionary relationship between Mad2 and
the meiotic HORMADs, plus the involvement of a shared
ATPase regulator, Pch2/TRIP13, strongly suggests mech-
anistic commonalities between these two protein families.
Recently, we showed that the C. elegans meiotic HOR-
MADs interact through association of their N-terminal
HORMAdomains with conserved closuremotifs at their C-
termini, and that the resulting hierarchical complex is essen-
tial for proper regulation ofCO formation and chromosome
segregation (83). We further identified closure motifs in
the C-termini of the mammalian meiotic HORMADs, and
demonstrated binding of these motifs to the HORMAD1
HORMA domain (83). In S. cerevisiae, prior genetic ev-
idence has demonstrated the importance of both its N-
terminal HORMA domain and a short, highly-conserved
C-terminal region (46,84,85). These features, plus addi-
tional evidence of Hop1 self-association in vitro (86), sug-
gest that Hop1 may also self-assemble through HORMA
domain–closure motif interactions. Importantly, there is
currently no evidence for homodimerization of meiotic
HORMADs (58), suggesting that these proteins’ assembly
mechanisms are distinct from those of Mad2. Thus, the
question of how meiotic HORMADs’ HORMA domain
conformation and closure motif binding activities are con-
trolled remains an important question. Specifically, as mei-
otic HORMADs have only been observed in their closed,
closure-motif bound conformation, it is not knownwhether
they adopt an ‘open’ conformation similar to Mad2 dur-
ing closure motif binding and dissociation. Indeed, no
HORMAdomain protein other thanMad2 has been shown
to possess the conformational dynamics that would seem
to be necessary for assembly and disassembly of HORMA
domain–closure motif complexes. Another major question
is how meiotic HORMADs are initially recruited to the
chromosome axis by coiled-coil ‘linker’ proteins such as
Red1, and whether this recruitment also involves HORMA
domain–closure motif interactions.
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Here, we present a detailed biophysical characteriza-
tion of the S. cerevisiae Hop1 HORMA domain. We iden-
tify related motifs in the Hop1 C-terminus and in Red1
that bind the Hop1 HORMA domain, indicating that
HORMA domain–closure motif interactions are responsi-
ble for both initial localization and self-assembly of Hop1
on the chromosome axis. We further find that the Hop1
HORMA domain displays conformational dynamics remi-
niscent ofMad2, and identify a new conformation of Hop1,
termed ‘unbuckled’, that likely functions analogously to
openMad2. These results outline the assembly mechanisms
of the meiotic chromosome axis and reveal a close struc-
tural and functional relationship between themeioticHOR-
MADs and Mad2.
MATERIALS AND METHODS
Protein expression and purification
Structural modeling. An initial structural model of the
Hop1 HORMA domain was generated using the One-to-
One Threading mode of the PHYRE2 server (http://www.
sbg.bio.ic.ac.uk/~phyre2/) usingC. elegansHTP-1 (PDB ID
4TZO, chain C) as a template (83), then this model was
manually adjusted. Side chain rotamers were not modeled.
Sequence similarity between closure motifs in S. cerevisiae
Hop1/Red1 andC. elegansHORMADs is not high enough
to accurately model the register of the closure motif peptide
in this model.
Protein purification. Hop12–255 andHop12–255 LLwere ex-
pressed in Escherichia coli strain Rosetta 2 (DE3) pLysS
(EMD Millipore, Billerica, MA, USA) at 20◦C for 16 h,
then cells were harvested by centrifugation and resuspended
in buffer A (20 mMTris pH 8.5, 10% glycerol) plus 300 mM
NaCl, 10 mM imidazole and 2 mM -mercaptoethanol.
Protein was purified by Ni2+-affinity (Ni-NTA agarose, Qi-
agen) and ion-exchange (Hitrap Q HP, GE Life Sciences,
Piscataway, NJ, USA) chromatography. Tags were cleaved
with TEV protease (87), and cleaved protein was passed
over a size exclusion column (Superdex 200, GE Life Sci-
ences) in buffer A plus 300 mM NaCl and 1 mM dithio-
threitol (DTT). Full-length Hop1 (wild-type and K593A),
Hop1584, and Red12–362 were purified as above, but at pH
7.5 instead of 8.5.
For size-exclusion chromatography coupled multi-angle
light scattering (SEC-MALS), proteins were separated on
a Superdex 200 Increase 10/300 GL size exclusion column
(GE Life Sciences) in a buffer containing 20 mM HEPES
pH 7.5, 300 mM NaCl, 10% glycerol, and 1 mM DTT.
Absorbance was measured at 280 nm, and light scatter-
ing and refractive index profiles collected by miniDAWN
TREOS and Optilab T-rEX detectors (Wyatt Technology,
Santa Barbara, CA, USA), respectively, and their molec-
ular weights calculated using ASTRA v. 6 software (Wy-
att Technology). For size-exclusion chromatography +/–
Red1345–362 peptide, proteins were pre-incubated with a 2-
fold molar excess of Red1345–362 peptide for 30 min at 4◦C,
then separated on a Superdex 200 Increase 10/300 GL size
exclusion column in a buffer containing 20 mM MES pH
6.0, 300 mM NaCl, 10% glycerol, and 1 mM DTT.
Protein interaction assays. Putative closure motifs in
Hop1 (residues 584–605) and Red1 (residues 330–362),
along with point-mutants, were cloned into a pET3a-based
vector with an upstream Kozak sequence and N-terminal
maltose binding protein (MBP) tag, and translated in vitro
with a TNT T7 Transcription/Translation kit (Promega)
with 35S-methionine. Ni2+ pulldown assays were performed
with C-terminally His6-tagged Hop11–255. 10 g purified
bait protein was incubated with 10 l of the translation
reaction in binding buffer (20 mM HEPES, pH 7.5, 150
mM NaCl, 20 mM imidazole, 5% glycerol, 1 mM dithio-
threitol (DTT), 0.1% NP-40) for 90 min at 4◦C, then 15 l
Ni-NTA beads were added, and the mixture was incubated
a further 45 min. Beads were washed three times with 0.5
ml buffer, then eluted with 25 l elution buffer (2× SDS-
PAGE loading dye plus 400 mM imidazole) and boiled.
Samples were run on SDS-PAGE, then the gel was dried and
scanned with a phosphorimager. For competition assays,
fluorescein isothiocyanate (FITC)-labeled competitor pep-
tides (Red1330–362 (FEDEKLGETFFHNVNNIPKISEVQ
NFLVLDYIE) and a sequence-scrambled version (NSVE
NFIVEGLIFNDKLEPLFHYKDNEETVIQ) were added
prior to addition of in vitro-translated protein, in 2-fold mo-
lar excess over bait protein.
Ni2+ pulldown assays were performed with purified His6-
MBP fused Red12–362 and Hop1584–605. 50 l reactions
with 10 g of bait protein plus 30 g of prey protein
(untagged full-length Hop1, Hop1 K593A, Hop12–255 or
Hop12–255LL) in binding buffer (20 mM HEPES pH 7.5,
300mMNaCl, 10mM imidazole, 10% glycerol, 1mMDTT,
0.1% NP-40) were incubated 2 hours at room temperature.
Samples were then mixed with 20 ul of magnetic Ni-NTA
beads (5% suspension; Qiagen) and incubated with rota-
tion for 30 min. Beads were washed three times with 0.5 ml
binding buffer, eluted with 25 l of elution buffer (2x SDS-
PAGE loading dye plus 400 mM imidazole) then boiled.
Samples were analyzed by SDS-PAGE, and visualized by
Coomassie Blue staining.
For fluorescence polarization peptide binding assays,
FITC-labeled peptides (BioMatik) at 50 nMwere incubated
with 12 nM–100 M Hop12–255 or Hop12–255LL in 50 l
binding buffer for 30 min, then transferred to a 384-well
black plate. Fluorescence polarization of triplicate reactions
were read using a Tecan Infinite M1000 PRO fluorescence
plate reader, and binding data were analyzed with Graph-
pad Prism v.6 using a single-site binding model.
Hydrogen–deuterium exchange mass spectrometry. HD ex-
change experiments were conducted with a Waters Synapt
G2S system. 5 ul samples in exchange buffer (20 mM
HEPES pH 7.5, 300 mM NaCl, 10% glycerol) were mixed
with 55 l of D2O buffer for several deuteration times
(10 s, 30 s, 1 min, 2 min, 5 min) at 15◦C. The exchange
was quenched for 2 min at 1◦C with an equal volume of
quench buffer (200 mM iodoacetic acid (IAA), 400 mM
Tris–HCl pH 8.5, 6.2 M urea, 2 mM EDTA). A portion
of the quenched sample (50 l) was injected onto an in-
line pepsin column (Applied Biosystems, Poroszyme Im-
mobilized Pepsin cartridge). The resulting peptic peptides
were then separated on a C18 column (Waters, Acquity
UPLC BEHC18, 1.7 m, 1.0 mm× 50 mm) fit with a Van-
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guard trap column using a 3–85% acetonitrile (containing
0.1% formic acid) gradient over 12 min at a flow rate of 40
l/min. The separated peptides were directed into a Wa-
ters SYNAPT G2s quadrupole time-of-flight (qTOF) mass
spectrometer. The mass spectrometer was set to collect data
in the MSE, ESI+ mode; in a mass acquisition range of
m/z 255.00−1950.00; with a scan time of 0.4 s. Continu-
ous lock mass correction was accomplished with infusion
of the LeuEnk peptide every 30 s (mass accuracy of 1 ppm
for the calibration standard). Peptides were identified us-
ing PLGS version 2.5 (Waters, Inc.). The relative deuterium
uptake for each peptide was calculated by comparing the
centroids of the mass envelopes of the deuterated samples
with the undeu- terated controls using DynamX version 2.0
(Waters Corp.).
For analysis of peptides showing bimodal HD exchange
behavior, assigned peaks for spectra collected at the 5-min
time-point were exported as mass/charge versus intensity,
normalized to a maximum intensity of 1.0 for each spec-
trum, and triplicate samples were fit in Graphpad Prism
(version 6; Graphpad Software) to either a single Gaussian
distribution:
Y = Amplitude ∗ e− (X−Mean)
2
2∗StDev2
where Amplitude is the amplitude, Mean is the mean, and
StDev is the standard deviation of the function, or a sum of
two Gaussian distributions:
Y =
(
Amplitudeone∗e−
(X−Meanone )2
2∗StDevone2
)
+
(
Amplitudetwo∗e−
(X−Meantwo)2
2∗StDevtwo2
)
where Amplitudeone, Meanoneand StDevone apply to the
first Gaussian function, and Amplitudetwo, Meantwoand
StDevtwo apply to the second.
RESULTS
Hop1 and Red1 possess similar Hop1 HORMA domain-
binding ‘closure motifs’
To better understand the functional parallels between S.
cerevisiae Hop1 and its orthologs in C. elegans and mam-
mals, we first sought to determine if Hop1 self-assembles
through interactions between its N-terminal HORMA do-
main and a C-terminal closure motif (83). Sequence align-
ments show that fungal Hop1 proteins share a highly con-
servedC-terminal Domain (CTD) of∼20 amino acids (Fig-
ure 1A). Prior work has shown that deletion of the C-
terminal 20 residues of Hop1, or mutation of the highly-
conserved ‘KIS’ motif spanning residues 593–595 (K593A
or S595N) dramatically reduces meiotic DSB and CO num-
bers and causes high spore lethality, indicating an impor-
tant role for this domain in Hop1 function (46,85,88). We
noticed that the Hop1 C-terminus bears limited sequence
homology with a region of Red1 previously shown to in-
teract directly with Hop1, notably including a ‘KIS’ motif
spanning Red1 residues 348–350 (Figure 1A) (24). Further,
a Red1 K348E mutant has previously been shown to elim-
inate its ability to bind Hop1, leading to reduced COs, de-
fective homolog synapsis, and low spore viability (24). To-
gether, the similarity of these motifs and their importance
for axis structure and function suggest that both Hop1 and
Red1 contain closure motifs that bind the Hop1 HORMA
domain.
We defined the HORMA domain of S. cerevisiae Hop1
by modeling the structure of this domain onto on our prior
structure of C. elegans HTP-1 (15% identity and 35% simi-
larity to Hop1 in this domain) (Figure 1B, Supplementary
Figure S1). We expressed and purified an isolated Hop1
HORMA domain construct (Hop12–255), and showed that
this truncated construct as well as full-lengthHop1 robustly
bind purified Red11–362, which encompasses the conserved
N-terminal domain of this protein plus the region previ-
ously shown to interact with Hop1 (Supplementary Figure
S2). Because of high protease-sensitivity of purified full-
length Red1, we were unable to demonstrate a direct in-
teraction between purified full-length Hop1 and Red1 pro-
teins.
We next tested binding of Hop12–255 to fluorescently-
labeled peptides encoding residues 345–362 of Red1 and
584–605 of Hop1. We detected robust binding between
Hop12–255 and the Red1345–362 peptide (Kd = 340 nM),
and weaker but detectable binding to the Hop1584–605 pep-
tide (Kd = 6 M) (Figure 2A). In both cases, binding
was abolished by point-mutations in the peptides based on
previously identified mutations, Hop1 K593A and Red1
K348E (Figure 2A) (46). We next used a Ni2+ pulldown
assay with His6-tagged Hop12–255 and in vitro-translated
Hop1584–605 or Red1345–362 (produced as maltose binding
protein fusions). As in the prior assays, we observed bind-
ing of the Hop1 HORMA domain to both peptides, that
was disrupted by mutation of the conserved lysine residue
in the ‘KIS’ motif (Hop1 K593A/Red1 K348E) (Figure
2B).Moreover, binding ofHop1584–605 toHop12–255 was dis-
rupted by addition of a two-fold molar excess of unlabeled
Red1345–362 peptide, revealing that the two putative closure
motifs compete for a common binding site on the Hop1
HORMAdomain (Figure 2B). Together, these data strongly
suggest that Red1 and Hop1 possess similar HORMA
domain-binding closure motifs. Further, Hop1 likely shares
the propensity to self-associate through HORMA domain-
CTDbinding with its orthologs inC. elegans andmammals.
When combined with prior data showing that the hop1-
K593Amutation causes an 11-fold reduction in COs and re-
sults in high spore lethality (46), our data argues that Hop1
self-association at the meiotic chromosome axis is critically
important for its regulatory functions.
As the Hop1 protein possesses a putative closure mo-
tif on its own C-terminus, this motif might be expected to
compete for binding to peptides added in trans. To test this
idea, we expressed and purified full-length Hop1, as well
as variants with either the K593A mutation (Hop1K593A)
or with residues 585–605 in the CTD deleted (Hop1584),
and tested their binding to the Red1345–362 peptide. Com-
pared to Hop12–255, we found that full-length Hop1 bound
Red1345–362 with dramatically lower affinity (Kd = 2Mver-
sus 340 nM forHop12–255). In contrast, bothHop1K593A (Kd
= 51 nM) and Hop1584 (Kd = 450 nM) bound Red1345–362
comparably to Hop12–255 (Figure 2C). Together, these data
suggest that while Hop1’s own CTD does compete with a
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Figure 1. Hop1 and Red1 contain putative ‘closure motifs’ with similar sequence. (A) Domain diagrams of S. cerevisiae Hop1 and Red1, with known
domains and domain boundaries marked (Zn2+: Hop1 domain containing a conserved Cys4-His-Cys3 motif predicted to bind zinc; CC: Red1 predicted
coiled-coil domain). Bottom: sequence alignment of putative closure motifs in Red1 and Hop1. (B) Structural model of the Hop1 HORMA domain, based
on the structure of C. elegansHTP-1 bound to a closure motif from HIM-3 (PDB ID 4TZO; (83). For sequence alignment, see Supplementary Figure S1.
The 5-C loop (residues 135–158) replaced with GSG in Hop12–255 LL is shown in green. The safety belt region is shown in magenta, and the bound
closure motif is shown in yellow.
Red1 peptide added in trans for HORMA domain binding,
the higher affinity of Red1 for the Hop1 HORMA domain
nonetheless likely enables Red1 to recruit full-length Hop1
directly to the chromosome axis.
The Hop1 HORMA domain adopts two distinct conforma-
tions in solution
During the purification of Hop12–255, we noticed that the
protein elutes from a size-exclusion column as two closely-
spaced peaks, one with an elution volume consistent with
a compact monomer and the other consistent either with a
dimer or an extendedmonomer (Figure 3A). Further analy-
sis by size exclusion chromatography coupled tomulti-angle
light scattering (Figure 3B) showed that both peaks con-
tain monomeric Hop12–255, demonstrating that the domain
can likely adopt two different conformations in solution:
one compact, and one more extended. We wondered how
these two conformations of Hop12–255 might relate to the
previously-described ‘closed’ and ‘open’ states ofMad2.We
found that pre-incubation of Hop12–255 with the Red1330–362
peptide shifted the equilibrium toward the later-eluting,
more-compact size exclusion peak (Figure 3A). This find-
ing suggests that the more-compact peak represents ‘closed’
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Figure 2. Closure motif peptide binding by Hop1. (A) Fluorescence polarization binding assays for Hop12–255 with four peptides: Hop1584–605 (blue, Kd
= 6.1 ± 1 M), Hop1584–605 K593A (dotted blue, Kd could not be fit), Red1345–362 (red, Kd = 340 ± 30 nM) and Red1345–362 K348E (dotted red, Kd could
not be fit). Error bars indicate standard deviation from triplicate measurements. (B) Ni2+-pulldown assay with His6-tagged bait MBP (maltose binding
protein; negative control) or Hop11–255 (C-terminal tag) and in vitro-translatedMBP-fused Red1330–362, Red1330–362 K348E, Hop1584–605, and Hop1584–605
K593A. Competitor peptides were added at a two-fold molar excess over bait protein. (C) FP Binding assay for Red1345–362 binding Hop12–255 (blue, Kd
= 340 ± 30 nM), full-length Hop1 (green, Kd = 2.0 ± 0.1 M), K593A (orange, Kd = 51 ± 5 nM), 584 (black, Kd = 450 ± 50 nM). See Supplementary
Figure S2 for Ni2+ pulldown assays of Hop1 binding Red11–362 and Hop1584–605.
Hop1 HORMA domain, and that the earlier-eluting, less-
compact peak represents a second, potentially open-like
conformation. Consistent with the idea that the HORMA
domain of full-length Hop1 can associate with its own C-
terminal tail, we fund that full-length Hop1 elutes from a
size-exclusion column as a monomer (Figure 3B).
To further examine the conformational differences be-
tween the two states of the Hop1 HORMA domain, we
generated several Hop12–255 variants based on mutations
known to stabilize either the open or closed conforma-
tion of Mad2 (66,89,90), and examined their behavior in
solution. While most variants destabilized Hop12–255, one
markedly improved expression and stability of the protein.
This mutant, referred to as ‘loopless’ or Hop1 LL (residues
135–158 replaced by a Gly-Ser-Gly linker), is based on the
Mad2 ‘loopless’ construct in which the extended 5-C
loop is replaced by a short linker (69). This mutation is
thought to inhibit O-Mad2 to C-Mad2 conversion by pre-
venting dissociation of the protein’s N-terminus from the5
strand, thereby disallowing safety belt movement and con-
version to the C-Mad2 state. The structural effect of this
mutant in Hop1 is difficult to predict, as the 5-C loop is
longer and more well-ordered in meiotic HORMADs than
in Mad2, draping over the safety belt -strands 8′ and 8′′
(Figure 1B) (83). We found that in contrast to wild-type
Hop12–255, Hop12–255LL migrated as a single species on a
size-exclusion column consistent with a compact monomer,
and that its elution profile was mostly unaffected by ad-
dition of the Red1330–362 peptide (Figure 3A, B). We next
tested binding of Hop12–255LL to the putative closure mo-
tif peptides Hop1584–605 and Red1345–362, and found that the
mutated protein robustly binds both peptides; indeed, the
loopless mutation seems to subtly increase peptide bind-
ing affinity compared to unmutated Hop12–255 (Figure 3C).
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Figure 3. The Hop1 HORMA domain shows two-state behavior in solution. (A) Size exclusion chromatography of Hop12–255 alone (blue),
Hop12–255+Red1330–362 (yellow), Hop12–255LL alone (green), andHop12–255LL:Red1330–362 (orange). (B) Size exclusion chromatography/multi-angle light
scattering (SEC-MALS) analysis of full-length Hop1 (absorbance at 280 nm in black, measured molecular weight in grey), Hop12–255 (blue, two peaks
defined as P1 and P2) and Hop12–255LL (green). Below: calculated and measured molecular weights for all constructs. (C) FP Binding assay for Hop12–255
LL binding putative closure motif peptides Hop1584–605 (blue), Hop1584–605 K593A (dashed blue), Red1345–362 (red), and Red1345–362 K348E (dashed red).
Error bars indicate standard deviation from triplicate measurements. Below: Peptide-binding Kd’s for Hop12–255 (from Figure 2A) and Hop12–255LL.
As the putative closure-motif binding site of Hop1 is not
altered in this mutant, we interpret this slightly-increased
affinity as indicating that the loopless mutation stabilizes
the peptide-binding conformation of the Hop1 HORMA
domain; namely, the ‘closed’ conformation.
Conformational dynamics of the Hop1 HORMA domain re-
vealed by hydrogen-deuterium exchange mass spectrometry
We next sought further structural insight into the rela-
tionship between Hop1 HORMA domain conformation
and peptide binding. As we were unable to identify crys-
tallization conditions for the Hop1 HORMA domain or
its complex with the Red1 closure motif, and low expres-
sion levels prevented examination by NMR, we instead
turned to hydrogen-deuterium exchange mass spectrometry
(HDX-MS). InHDX-MS, exchange of backbone amide hy-
drogen atoms with deuterium from D2O-containing buffer
provides information on the solvent-accessibility and sec-
ondary structure of different regions of a protein. We
detected mass spectra for a set of common peptides in
Hop12–255 and Hop12–255LL (covering 61% and 70% of
the two constructs, respectively), including the C-terminal
safety belt region but notably excluding the 5-C loop
(deleted in the Hop1 LL mutant, and not detected in
Hop12–255) and theN-terminus (Supplementary Figure S3A
and B). The rates of deuterium uptake in different regions
largely agreed with predicted secondary structure in our
model of the Hop1 HORMA domain based on C. elegans
HTP-1 in the ‘closed’ conformation (Supplementary Figure
S3C and D) (83). This was especially true for Hop12–255LL,
which our size-exclusion chromatography analysis shows
adopts exclusively the more-compact conformation.
We next compared HDX-MS profiles of Hop12–255 and
Hop12–255LL in the absence and presence of the Red1345–362
peptide. We found that all regions of Hop12–255 become
more protected from H-D exchange in the presence of
Red1345–362 (Supplementary Figure S4A). Supporting our
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assignment of Red1345–362 as a closure motif, Hop12–255 re-
gions predicted to lie adjacent to the closure motif bind-
ing site, including residues 182–195 and 198–211, are the
most protected uponRed1345–362 binding (Figure 4A, D, E).
Residues 91–99 in helix B, which is positioned just behind
the closure motif binding site, as well as residues 74–90 in
the 2-3 hairpin adjacent to helix B, also show a high
degree of protection upon Red1345–362 binding (Figure 4B
and E). Finally, we also observed significant protection in
regions corresponding to the 8′ and 8′′ strands of the
safety belt (residues 234–248), as well as helix C (residues
164–173), which packs against these -strands in the closed
HORMAdomain conformation (Figure 4C and E). Signifi-
cant protection of the safety belt and adjacent regions upon
binding of Red1345–362 strongly suggests that the two Hop1
conformations we observe in solution differ largely in the
conformation of the safety belt, consistent with the known
conformational changes of Mad2.
In Hop12–255LL, H-D exchange rates for most regions,
including peptides within and adjacent to the safety belt
(residues 165–173 and 234–248), are much less affected by
the addition of Red1345–362 than in wild-type Hop12–255,
supporting the idea that this mutant pre-forms the more-
compact closed conformation in the absence of closure mo-
tif peptides (Figure 4C, Supplementary Figure S4B). No-
table exceptions include residues 182–195 and 198–211,
whichmake up the putative closure motif binding site: these
regions would be expected to show different H-D exchange
rates based on closure motif binding alone (Figure 4A and
F). Thus, Hop12–255LL likely adopts an ‘empty’ closed con-
formation, to which closure motif peptides can directly as-
sociate without HORMA domain conformational conver-
sion.
Our size-exclusion chromatography data showed that in
the absence of a bound peptide, Hop12–255 adopts two
different conformations in solution. Consistent with this
finding, a number of peptides in the Hop12–255 construct
show a bimodal distribution of H-D exchange rates (Fig-
ure 5). Bimodal H-D exchange rate distributions arise
when the region in question can stably adopt two dif-
ferently solvent-exposed conformations, resulting in high-
exchanging (more solvent-exposed) and low-exchanging
(less solvent-exposed) populations. The regions showing
the most pronounced bimodality include residues 234–
248, spanning 8′ and 8′′ in the safety belt (Figure 5B),
residues 164–173 in the adjacent C-helix (Figure 5C), and
residues 40–49 and 74–90 in the 2-3 hairpin (Figure
5D-F). These peptides’ bimodal behavior is nearly elimi-
nated in the presence of the Red1345–362 peptide, and they
all show a monomodal H-D exchange rate distribution in
Hop12–255LL regardless of Red1345–362 binding (Figure 5A–
C). Taken together, our HDX-MS data as a whole sup-
ports our identification of two stable conformations of the
Hop1HORMAdomain, and suggest that the two states dif-
fer largely in the conformation of the domain’s C-terminal
safety belt region. While the strong bimodality in H-D ex-
change rates in these regions of wild-type Hop12–255 shows
that this construct populates both states in solution, ad-
dition of the Red1345–362 peptide shifts the equilibrium
strongly in favor of the ‘closed’ conformation (Figure 5G).
Hop12–255LL shows a strong bias toward the closed state
on its own, which is further shifted toward this state upon
binding the Red1345–362 peptide.
DISCUSSION
In this study, we present a combined biochemical and
biophysical characterization of the S. cerevisiae meiotic
HORMA domain protein Hop1, identifying Hop1-binding
closure motifs in both Hop1 and its binding partner Red1,
and characterizing two distinct conformations of the Hop1
HORMAdomain.When combined with prior genetic data,
our results strongly suggest that HORMA domain–closure
motif interactions underlie both the initial association and
self-assembly of Hop1 onmeiotic chromosomes. As bothC.
elegans and mammalian meiotic HORMADs self-assemble
through HORMA domain–closure motif interactions (83),
and most eukaryotes possess a Red1-like ‘linker’ protein re-
quired for axis assembly, our results suggest that initial asso-
ciation of meiotic HORMADs with meiotic chromosomes
may also be mediated by HORMA domain–closure motif
interactions. In C. elegans, our earlier work suggested that
HTP-3 may bind directly to a subunit of the cohesin com-
plex (83). Mammalian HORMAD1 and HORMAD2 may
also bind cohesin complexes directly, or alternatively bind
a closure motif in SYCP2 or SYCP3, in a parallel of the
Hop1-Red1 association (22,91).
Our data suggest that Hop1 initially binds chromosomes
through a closure motif in Red1, followed by additional
Hop1 recruitment via head-to-tail oligomerization (Figure
6A). The competition we observe betweenRed1 andHop1’s
own C-terminus for binding the HORMA domain suggests
that in solution, Hop1 tends to form a ‘self-closed’ state
but that recruitment of Hop1 to the chromosome axis by
Red1 displaces the Hop1 CTD from the HORMA domain.
This free CTD may in turn bind the HORMA domain of
a second Hop1 monomer, initiating multimeric assembly.
A conceptual problem with this model is that if the Hop1
HORMA domain can interact with a closure motif at its
ownC-terminus, the high local concentration of this closure
motif would be expected to preclude binding to a second
Hop1 monomer in trans. Hop1 oligomerization on the axis
would only be favored if steric constraints not present in our
reconstituted system were to inhibit self-interaction relative
to oligomerization. Such constraints could include post-
translational modifications and/or protein–protein interac-
tions, such as the known phosphorylation of theHop1 SCD
region, which mediates recruitment of the Mek1 kinase
(5,6,43,45,46). Pch2may also contribute to Hop1 oligomer-
ization (at least in some systems; see below), but its role
is likely to be purely kinetic; that is, Pch2 could generally
stimulate Hop1 conformational dynamics, but is unlikely
to alter the equilibrium Hop1 oligomer length unless it is
specifically localized to chromosomes (see below). While
we are not yet able to explain the physical basis for Hop1
oligomerization, the strong effects on DSB and CO lev-
els, homolog synapsis, and overall spore viability observed
whenmutating or deleting theHop1CTD (46,85) constitute
strong indirect evidence that Hop1 oligomerization plays
a key role in CO formation. Interestingly, the CO defect
caused by a hop1-K593A mutant can be rescued by ectopic
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Figure 4. HD exchange in Hop12–255 and Hop12–255 LL. (A) Deuterium uptake plots of Hop1 residues 182–195 and 198–211, corresponding to the 6
strand and putative closure motif binding site, for Hop12–255 (blue, +Red345–362 in yellow) and Hop12–255LL (green, +Red345–362 in orange). (B) Uptake of
residues 74–90 and 91–99, corresponding to the 2–3 hairpin and helix B. (C) Uptake of residues 164–173 and 234–248, corresponding to portions of
the C-helix and 8′-8′′ of the safety belt. See Supplementary Figure S3 for exchange data on all detected peptides. (D) Structural model of Hop12–255
showing regions described in panels (A–C): closure motif binding site (light blue), 2–3 hairpin and helix B (light green), and safety belt (pink). (E)
Structural model ofHop12–255 colored according to the difference in relative deuterium uptake between the unbound andRed1345–362 bound state.Magenta
indicates no change in HD exchange rate, and blue indicates significantly less exchange (more protection) upon binding the closure motif peptide. Regions
shown in gray were not detected. (F) Structural model of Hop12–255LL, showing protection upon binding Red1345–362 as in panel (E). See Supplementary
Figure S4 for exchange differences over time for Hop12–255 and Hop12–255LL ± Red1345–362 peptide.
dimerization ofMek1, through its fusion to the dimeric glu-
tathione S-transferase protein (46). This result suggests that
one role of Hop1 self-association is to activate Mek1, likely
by bringing multiple copies of the kinase into close proxim-
ity at the chromosome axis to enable trans-autoactivation
(Figure 6A). Notably, the defect in both DSB and CO lev-
els in a hop1-K593A strain is significantly less severe than
in hop1Δ, and the Hop1 K593A mutant protein behaves
well in vitro (this work) and localizes to meiotic chromo-
somes (46). These data support the idea that Red1 can re-
cruit Hop1 directly, but that additional Hop1 recruitment
through head-to-tail binding is nonetheless required to sup-
port wild-type levels of DSB formation and Mek1 kinase
activation, which combine to support CO formation.
In addition to the meiotic HORMADs, HORMA do-
mains are found inMad2, Rev7, and two autophagy-related
proteins, Atg13 and Atg101 (57,65). While Mad2 has been
shown to adopt two stable conformations in solution, simi-
lar conformational dynamics have not been observed in any
other HORMA domain protein family (65). Here, we show
for the first time that the S. cerevisiae meiotic HORMAD
Hop1 can adopt two different stable states in solution: a
closed conformation similar towhat we previously observed
for the C. elegansmeiotic HORMADs (83), and a more ex-
tended conformation. Our HDX-MS data indicate that the
two states differ mainly in the conformation of the protein’s
C-terminal safety belt region, and that this region is prob-
ably disengaged from the HORMA domain core in the ex-
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Figure 5. Bimodal HD exchange in Hop12–255. (A) Graphs showing normalized peak intensity versus mass/charge ratio (m/z) at 5 min exposure to D2O
for an example monomodal peptide, Hop191–99. Top:Hop12–255, alone (blue) and with Red1345–362 (yellow).Bottom:Hop12–255 LL alone (green), and with
Red1345–362 (orange). Each dataset was fit to a single Gaussian distribution. (B) Graphs for Hop1234–248 showing a bimodal distribution of HD exchange.
Hop12–255 alone was fit to a sum of two Gaussian distributions, and the other three sampleswere fit to a single Gaussian distribution. (C) As (B), for
Hop1164-173. For this peptide, both Hop12–255 samples (with and without the Red1345–362 peptide) were fit to a sum of two Gaussian distributions, while
the Hop12-255 LL samples were fit to a single Gaussian distribution. (D and E) Graphs for Hop140–49 and Hop174–90, showing only data for Hop12–255
(data for Hop12–255 LL was not annotated well enough to fit). (F) Location of peptides showing bimodal HD exchange behavior (blue) on the modelled
structure of Hop12–255 bound to a closure motif (yellow). (G) Schematic of proposed Hop1 HORMA domain equilibrium in four states. Hop1LL (green)
shows a strong bias toward the closed conformation compared to wild-type (blue), while addition of the Red1345–362 peptide to either wild-type (yellow)
or loopless Hop1 (orange), further shifts the equilibrium toward the closed conformation.
tended state. This model contrasts with Mad2’s open con-
formation, in which the safety belt is stably associated with
the closure-motif binding site, generating a structure that is
similarly compact to the protein’s closed conformation (92)
(Figure 6B). The extended state of the Hop1 HORMA do-
main may therefore correspond more closely with the theo-
rized transient Mad2 intermediate state, in which the safety
belt has disengaged from the HORMA domain core to al-
low Cdc20 closure motif binding (62,69) (Figure 6B). Be-
cause the term ‘intermediate’ hasmore recently been used to
refer to a compact Mad2 conformation adopted just prior
to this conformational change (75), we instead introduce the
term ‘unbuckled’ to refer to a HORMA domain conforma-
tion in which the safety belt is stably disengaged from the
HORMA domain (Figure 6C).
While we designed the Hop1 ‘loopless’ mutation based
on a Mad2 variant that stabilizes this protein’s open con-
formation (69), this mutation appears to stabilize the closed
conformation in Hop1. In Mad2, truncation of the 5–C
loop is thought to disallow dissociation of the protein’s N-
terminal 1 strand from strand 5 in the HORMA domain
core, thereby inhibiting the open-to-closed conformational
change (69). We propose that Hop1 may not possess an N-
terminal 1 strand, and that the ‘unbuckled’ conformation
is instead stabilized by the extended 5-C loop itself. As
this loop is much longer in meiotic HORMADs than in
Mad2 (24 residues in Hop1 versus 9 in Mad2), the loop
could bind against 5 after safety belt dissociation to sta-
bilize the unbuckled state. In this scheme, truncation of the
5-C loop would be expected to destabilize the unbuck-
led state, thereby favoring the closed state as we observe for
Hop12–255LL (Figure 6C). It is important to note that, while
Hop12–255LL binds closure-motif peptides at least as tightly
as wild-type Hop12–255, this mutant is likely to be strongly
defective in vivo. As binding of a closure-motif peptide to
an ‘empty’ closed Hop1 requires that the peptide thread un-
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Figure 6. Model for Hop1 HORMA domain dynamics and meiotic chromosome axis assembly/disassembly. (A) Cartoon model of Hop1’s recruitment,
multimeric assembly, and disassembly along the chromosome axis. Hop1 (dark blue) is recruited to chromosomes by binding the Red1 closure motif
(yellow). The displaced Hop1 CTD closure motif serves to recruit additional copies of Hop1 (lighter blue) to the chromosome axis. Hop1 oligomerization
facilitates the trans-autoactivation of Mek1, resulting in a suppression of sister chromosome strand invasion and biasing DSB repair toward the homolog.
After CO formation, Pch2 facilitates the removal of Hop1 from the axis by disrupting closure-motif interactions as the synaptonemal complex forms.
(B) Cartoon representation and energy diagram of the Mad2 safety belt mechanism. The dimerization-stimulated conversion of O-Mad2 to C-Mad2,
coupled to closure motif binding, requires dissociation of the N-terminus from the core of the HORMA domain and translocation of the safety belt
(magenta). TRIP13 facilitates the conversion back to O-Mad2 by disengaging the safety belt from the HORMA domain core. (C) Cartoon representation
and energy diagram of the proposed Hop1 safety belt mechanism. Closure motif binding stabilizes the closed state by promoting binding of the safety belt
(magenta) to the HORMA domain core. The 5-C loop (green) stabilizes the ‘unbuckled’ state through an unknown mechanism. Pch2/Trip13 promotes
a closed-to-unbuckled conformational change of Hop1 by disengaging the safety belt from the HORMA domain core.
derneath part of the safety belt region, binding of the Red1
closure motif (more than 300 amino acids from either ter-
minus of Red1) would be expected to require a conforma-
tional change in Hop1, much as in Mad2. We have so far
been unable to test the function of Hop1 LL in S. cerevisiae,
due to extremely poor expression of the mutant protein in
meiotic cells. As Hop12–255LL is more highly expressed in
Escherichia coli than the wild-type protein and is extremely
stable in solution, the low levels of Hop1 LL we observe in
S. cerevisiae may indicate that the protein is unstable, per-
haps due to an inability to assemble on meiotic chromo-
somes.
Our data indicate that in S. cerevisiae, chromosome axis
assembly is mediated in large part by binding of the Hop1
HORMA domain to closure motifs in both Hop1 and
Red1. In contrast to Mad2, where assembly with Cdc20
occurs specifically at unattached kinetochores through
dimerization-catalyzed conformational conversion, we en-
vision meiotic chromosome axis assembly to be largely
spontaneous. A major remaining question, however, is how
meiotic HORMADs are removed from the chromosome
axis by Pch2/TRIP13 in coordination with synaptonemal
complex assembly (Figure 6A). We have recently shown
that mammalian TRIP13 binds the disordered N-terminus
of Mad2 and then partially unfolds the protein to medi-
ate the disengagement of the Mad2 safety belt from the
HORMA domain core (76,93). We further showed that
N-terminal truncation of mouse HORMAD1 inhibits its
TRIP13-mediated disassembly from meiotic chromosome
axes, highlighting a common remodeling mechanism with
Mad2 (93). We propose that Pch2/TRIP13 may be im-
portant to drive HORMA domain conformational dy-
namics and closure motif association/dissociation in mei-
otic HORMADs throughout eukaryotes. In this scheme,
synaptonemal complex assembly likely triggers recruitment
of Pch2/TRIP13 to the chromosome axis, where it re-
moves HORMADs by disassembling HORMA domain–
closure motif interactions. An important question in this
regard is whether there exist two pools of meiotic HOR-
MADs on chromosome axes, distinguished by their bind-
ing partners: in both S. cerevisiae and mammals, not all
Hop1/HORMAD1 is removed from the axis upon synap-
tonemal complex assembly (11–13,28,94). This finding, plus
the higher affinity of Hop1 for the Red1 closure motif and
the location of the Red1 closure motif far from either ter-
minus of this protein, suggests that Pch2 might more ef-
fectively disassemble Hop1–Hop1 complexes compared to
Hop1–Red1 complexes.
In some systems, notably the rice Oryza sativa, mutation
of Pch2/TRIP13 causes a loss of initial association of mei-
otic HORMADs with the chromosome axis (95). This ob-
servation suggests another potential role of Pch2/TRIP13,
that also parallels earlier findings with Mad2. In the spin-
dle assembly checkpoint, a pool of O-Mad2 is required
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for kinetochore-recruitment and assembly with Cdc20, and
TRIP13 is required to maintain this pool of O-Mad2
by converting empty C-Mad2 to the open conformation
(76,96). In a similar vein, if the meiotic HORMADs in a
given organism are much more stable in the closed confor-
mation, Pch2/TRIP13 may be required to stimulate their
dynamics to promote initial assembly of the chromosome
axis, in addition to its later functions in HORMAD dis-
assembly. Overall, the role of Pch2/TRIP13 in promoting
function of meiotic HORMADs, and especially its detailed
mechanism of meiotic HORMAD recognition and remod-
eling, will be an interesting avenue for future research.
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